EGFR and cancer: Our findings provide further evidence indicating that the highly accurate and quantitative NOIR-SS is useful in clinical settings in addition to established advantages of NGS methodologies such as the concurrent interrogation of the entire EGFR tyrosine kinase domain and a number of other cancer-relevant genes.